Finance

Private finance, alliances drive Swiss biotech

Read more

BioPharma updates 2025 forecasts with some cautions

Read more

Biotechs shift priorities amidst financing challenges

Read more

Swiss companies weather the turmoil in 2022

Read more

New era for drug pricing in US

Read more

Spotting biotech opportunities in a changing market

Read more

How European MidPharmas have grown profits

Read more

Swiss biotech attracted record financing in 2020

Read more

How exchange traded funds could benefit Europe

Read more

Forbion to create and grow biotech companies

Read more